Skip to main content

Targeted Therapy to Augment the Adult Malignant Glioma Therapeutics Market

Home » Press Release » Targeted Therapy to Augment the Adult Malignant Glioma Therapeutics Market

May 17, 2022

Targeted Therapy to Augment the Adult Malignant Glioma Therapeutics Market

The global adult malignant glioma therapeutics market is anticipated to observe a remarkable growth at a CAGR of 9.3% and may reach the valuation of USD 2,964.5mn during the forecast period 2022 to 2027.

The growing adoption of novel and targeted therapies is expected to drive the global adult malignant glioma therapeutics market in the following years.

ResearchMoz sheds some light on the changing market tendencies including size, trends, opportunities, growth drivers, restraints, and competitive edge.

Factors Driving and Restraining Market

Some of the factors that are expected to drive the global adult malignant glioma therapeutics market.

  • The rising prevalence of tumours is expected to drive the global adult malignant glioma therapeutics during the forecast years.
  • Increasing investments in the field of research and development regarding targeted therapies are expected to boost the demand for the adult malignant glioma therapeutics market in the forecast period.
  • The advanced targeted therapies have been showing some improvement in the survival rates, leading to the expansion of the global adult malignant glioma market.
  • Growing government support for drug development and novel therapies are expected to push the global adult malignant market to expand in the following years.

Some of the restraints that could pose challenges in the global adult malignant glioma therapeutics are –

  • Side effects of the treatments associated with the adult malignant glioma are expected to hinder the market growth during the forecast period.
  • Further, the treatment being costly could dampen the global adult malignant glioma therapeutics market in the coming years.

Nonetheless, the new way of imaging using an infra-red camera which helps in retaining the healthy tissues is expected to boost the demand for the adult malignant glioma therapeutics market.

Analyst’s Views

The global adult malignant glioma therapeutics market is foreseen as thriving at a significant rate in the coming years.

The adult malignant glioma is the most common tumour which is why the adult malignant glioma therapeutics market is anticipated to have a greater demand.

The targeted therapy segment is expected to hold a larger share in the global adult malignant glioma market in the following years.

The glioblastoma multiforme is expected to thrive in the following years as it is the common tumour in the adult malignant glioma market during the forecast years.

Asia Pacific region is expected to dominate the global adult malignant glioma therapeutics market in the following years due to better health infrastructure at affordable cost and the large patient pool in the developing economies.

Simultaneously, North America is expected to drive the global adult malignant glioma therapeutics market in the coming years due to the availability of advanced technology.

Competitive Landscape

The global adult malignant market includes prominent players in the market-

  • Arbor Pharmaceuticals,
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Hoffmann-La Roche Ltd
  • Sun Pharmaceuticals Ltd
  • Emcure Pharmaceuticals Limited.
  • Bristol-Myers Squibb Company
  • Amgen Inc.

Key Takeaways

  • The global adult malignant glioma is expected to grow substantially over the next few years as this is the most common type of tumour in adults across the globe.
  • The market is growing phenomenally well in the Asia Pacific region, thanks to developing countries with improved medical care facilities,
  • The high demand for novel and targeted therapies are expected to drive the global adult malignant glioma therapeutics market over the next few years.
  • The rising importance and investment to research and development in the drug development is expected to expand the global adult malignant therapeutics market in the following years.

Media Contact

Please drop a mail to the Global PR Team for your queries

Contact Us

We Are Just A Click Away!

[email protected]
+1-518-621-2074